Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2003
11/26/2003CN1128801C Triazolo (4,5-D) pyrimidine compounds
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128799C Photoactivatable nitrogen-containing alkali based on alpha-amino alkenes
11/26/2003CN1128798C Pharmaceutically active tricyclic amines
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/25/2003US6653500 Making ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine from 2,3-dichlorobenzaldehyde, reducing the glycine compound using tin dichloride or a catalyst and cyclization of the corresponding iminoquinazoline compound
11/25/2003US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction
11/25/2003US6653470 Process for the preparation of 1,4,7,10-tetraazacyclododecane
11/25/2003US6653337 Active ingredient mono-L-aspartyl chlorin e6 or mono-L-glutamyl chlorin e6 or salt
11/25/2003US6653331 Targeted drug delivery using sulfonamide derivatives
11/25/2003US6653320 Such as 3-(6-bromo-2-methylimidazo(1,2-a)pyridin-3-yl)-1H-pyrazol-1-yl 2-methyl-5-nitrophenyl sulfone; useful as phosphatidylinositol-3-kinase (PI3K) inhibitors and antitumor agents
11/25/2003US6653315 Substituted 5-amino-imidazolo-(4,3-e)-1,2,4-triazolo(1,5-c)-pyrimidines; central nervous system diseases; Parkinson's disease
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653295 Protease inhibitor; viricide
11/25/2003US6653290 Tumor proliferation inhibitors
11/25/2003CA2106370C Antibiotic compounds
11/25/2003CA2061168C The preparation and use of 3, (4)-substituted pyrrolidines as catalysts for the polyisocyanate polyaddition process
11/20/2003WO2003095505A1 Fluorinated polymers
11/20/2003WO2003095457A1 Adenosine a3 receptor modulators
11/20/2003WO2003095456A1 A process for the preparation of zaleplon
11/20/2003WO2003095455A2 Substituted pyrazolopyrimidines
11/20/2003WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/20/2003WO2003095427A1 Spiro-ring compound
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003063764A3 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
11/20/2003WO2003028629A3 Chlorin photosensitizing agents for use in photodynamic therapy
11/20/2003WO2003022804A3 Method for the preparation of crystalline tetrahydrobenzothiepines
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003WO2002028861A8 Methods and compounds for treating proliferative diseases
11/20/2003US20030216603 Fluorinated quaternary ammonium salt
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216416 Novel crystalline of n-[4-[2-(2-amino-4,7-dihydro-4oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process therefor
11/20/2003US20030216411 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216401 Anti-obesity 1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2-a] indoles
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216395 Imidazo-triazine derivatives as ligands for GABA receptors
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216379 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/20/2003US20030216374 Antibiotic oxazolidinone derivatives
11/20/2003US20030216324 Five-member heterocyclic compounds substituted with an alpha-amino carbonyl group; antiasthma agents
11/20/2003CA2482545A1 A process for the preparation of zaleplon
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/20/2003CA2451081A1 Adenosine a<sb>3</sb> receptor modulators
11/19/2003EP1362858A1 Pyrrolopyrimidinone derivates, process of preparation and use
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362382A1 Aryl-aryl dendrimers
11/19/2003EP1362081A1 Acid pigment dispersants and pigment preparations
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362049A1 Novel pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1066289B1 Preparation of n-arylarylsulfonamide compounds
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
11/19/2003CN1456154A Method for curing sepsis
11/18/2003US6649771 Silver halide color photographic light-sensitive material, pyrrolotriazole compound and dye-forming compound
11/18/2003US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
11/18/2003US6649759 Pyrazolo(1,5-a)pyrimidine derivatives; treating feeding, cardiovascular and psychological disorders
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/18/2003CA2072233C Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists; processes for preparing them and pharmaceutical compositions containing them
11/13/2003WO2003093273A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003WO2003093272A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003WO2003093271A1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines
11/13/2003WO2003093270A1 5-ethyl-imidazo (5,1-f) (1,2,4,) triazin-4 (3h) -ones as phosphodiesterase inhibitors
11/13/2003WO2003093269A2 Substituted pyrazolo-pyrimidine-4-ones
11/13/2003WO2003093268A1 7-aminoimidazotriazones
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003080617A8 Pyrazolopyrimidine derivatives
11/13/2003WO2003032897A3 Azabicyclic compounds for the treatment of fibromyalgia syndrome
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003US20030212273 Pyrrolo [2,3-D] pyrimidine compounds
11/13/2003US20030212268 Reacting glycoluril with formaldehyde; separation, purification
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212115 Remedies for inflammatory bowel diseases
11/13/2003US20030212101 Respiratory system disorders; antiinflammatory agents; psychological disorders
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212080 Adenosine A2a receptor antagonists
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030212064 Triazolotriazinones and the use thereof
11/13/2003US20030212059 Adenosine A2a receptor antagonists
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003US20030211044 Administering palladium-porphyrin complex; irradiation
11/13/2003US20030209243 Dry powder dispersing apparatus and methods for their use
11/13/2003CA2484997A1 Substituted pyrazolo-pyrimidine-4-ones
11/13/2003CA2484983A1 5-ethyl-imidazo (5,1-f) (1,2,4,) triazin-4 (3h) -ones as phosphodiesterase inhibitors
11/13/2003CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003CA2484162A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003CA2483865A1 7-aminoimidazotriazones
1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 573